Aoxing Pharmaceutical Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.02
52-Week Range
Now: $0.01
Volume18,000 shs
Average Volume72,026 shs
Market Capitalization$1.05 million
P/E RatioN/A
Dividend YieldN/A
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:AOXG
Previous SymbolNYSEMKT:AXN
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$1.05 million
Next Earnings DateN/A
OptionableNot Optionable


Aoxing Pharmaceutical Co. Inc.
October 1, 2020 |  wsj.com
Aoxing Pharmaceutical Company, Inc. (AOXG)
March 26, 2020 |  finance.yahoo.com
Aoxing Pharmaceutical Co Inc
March 19, 2019 |  www.bloomberg.com
See More Headlines


Overall MarketRank

0.48 out of 5 stars

Medical Sector

1624th out of 2,015 stocks

Pharmaceutical Preparations Industry

679th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AOXG News and Ratings via Email

Sign-up to receive the latest news and ratings for AOXG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aoxing Pharmaceutical (OTCMKTS:AOXG) Frequently Asked Questions

What stocks does MarketBeat like better than Aoxing Pharmaceutical?

Wall Street analysts have given Aoxing Pharmaceutical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aoxing Pharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Aoxing Pharmaceutical's earnings last quarter?

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) released its earnings results on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $6.56 million for the quarter.
View Aoxing Pharmaceutical's earnings history

How has Aoxing Pharmaceutical's stock price been impacted by COVID-19?

Aoxing Pharmaceutical's stock was trading at $0.0076 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AOXG stock has increased by 81.6% and is now trading at $0.0138.
View which stocks have been most impacted by COVID-19

Who are Aoxing Pharmaceutical's key executives?

Aoxing Pharmaceutical's management team includes the following people:
  • Mr. Zhenjiang Yue, Chairman and Chief Exec. Officer (Age 62, Pay $155.32k)
  • Mr. Guoan Zhang, CFO, Chief Accounting Officer & Sr. VP of Fin. (Age 51)
  • Ms. Yunlan Tang, Chief Engineer (Age 75)
  • Wei Zhang, Corp. Sec.
  • Ms. Guirong Zhou, Pres of R&D (Age 67)
  • Ms. Hongyue Hao, Vice Gen. Mang. of Financial Operations (Age 50)

Who are some of Aoxing Pharmaceutical's key competitors?

What other stocks do shareholders of Aoxing Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), Spark Networks (LOV), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC), Edap Tms (EDAP), Fortress Biotech (FBIO), Inovio Pharmaceuticals (INO) and Pernix Therapeutics (PTX).

What is Aoxing Pharmaceutical's stock symbol?

Aoxing Pharmaceutical trades on the OTCMKTS under the ticker symbol "AOXG."

How do I buy shares of Aoxing Pharmaceutical?

Shares of AOXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aoxing Pharmaceutical's stock price today?

One share of AOXG stock can currently be purchased for approximately $0.01.

How much money does Aoxing Pharmaceutical make?

Aoxing Pharmaceutical has a market capitalization of $1.05 million.

How many employees does Aoxing Pharmaceutical have?

Aoxing Pharmaceutical employs 346 workers across the globe.

What is Aoxing Pharmaceutical's official website?

The official website for Aoxing Pharmaceutical is axzyen.icm.cn.

Where are Aoxing Pharmaceutical's headquarters?

Aoxing Pharmaceutical is headquartered at FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404.

How can I contact Aoxing Pharmaceutical?

Aoxing Pharmaceutical's mailing address is FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404. The company can be reached via phone at 86-311-8961-8579 or via email at [email protected]

This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.